Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted Treatment
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
Pfizer
Essen Biotech
National Institutes of Health Clinical Center (CC)
Incyte Corporation
St. Jude Children's Research Hospital
Prescient Therapeutics, Ltd.
City of Hope Medical Center
Seagen Inc.
OncoNano Medicine, Inc.
Columbia University
National Cancer Institute (NCI)
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Arcus Biosciences, Inc.
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Case Comprehensive Cancer Center
City of Hope Medical Center
Mayo Clinic
City of Hope Medical Center
Cedars-Sinai Medical Center
Daiichi Sankyo
Checkpoint Therapeutics, Inc.
National Cancer Institute (NCI)
City of Hope Medical Center
Celldex Therapeutics
Stanford University
Stanford University
Peking University First Hospital
University of Nebraska
University of Nebraska
National Cancer Institute (NCI)
Children's Oncology Group
University of Nebraska
Eastern Cooperative Oncology Group
Stanford University
Seagen Inc.
Bristol-Myers Squibb
Atara Biotherapeutics
Karyopharm Therapeutics Inc
Scripps Health
Columbia University
Thomas Jefferson University
Roswell Park Cancer Institute
Opna Bio LLC
miRagen Therapeutics, Inc.
Northwestern University
Roswell Park Cancer Institute